genmedics is an international operating biotechnology company that is focused on the search for, development and production of new anti-infectives. Founded as a spin-off from the Department of Microbial Genetics of the University of Tübingen in 1998, genmedics has developed a distinct expertise in the bacterial genus staphylococcus. Part of genemdics´ vision involves interfering with the pathological mechanisms of staphylococci while on the other hand using the apathogenic Staphylococcus carnosus as a safe system for expressing therapeutic proteins and gene therapeutics.

Take the opportunity to explore our expertise in the bacterial genus Staphylococcus, our variety of specialty products for scientific and industrial use, or look how our exceptional resources can be your partner in the entire research process or, if desired, for discreet stages thereof.